These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4641625)

  • 21. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I; Midura-Nowaczek K; Kaczyńska J; Krajewska D
    Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation and fibrinolysis.
    Heimburger N; Trobisch H
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Nov; 108(11):655-75 contd. PubMed ID: 5378688
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of the components of fibrinolytic system].
    Slobozhankina IK
    Lab Delo; 1973; 11():662-4. PubMed ID: 4132568
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the question of fibrinolytic factors in the placenta].
    Halberstadt E; Stein WW; Michel RT; Glück W
    Arch Gynakol; 1968; 206(4):450-5. PubMed ID: 5306076
    [No Abstract]   [Full Text] [Related]  

  • 27. [The fibrinolytic actiity of urine and its susceptibility to natural and synthetic antifibrinolytic agents].
    Vogel G; Sundermann A; Kresch K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):182-6. PubMed ID: 4174657
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP; Ferguson JH
    Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468
    [No Abstract]   [Full Text] [Related]  

  • 29. [Research on a new fibrinolytic agent extracted from human placenta (Thromboclase)].
    Ponari O; Dallavalle L; Dettori AG; Gallese R
    Therapie; 1968; 23(4):737-50. PubMed ID: 4245312
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibitory effect of normal and cancerous tissues of the bladder on plasminogen activation.
    Hisazumi H
    Invest Urol; 1973 Nov; 11(3):258-62. PubMed ID: 4270696
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antifibrinolytic therapy of gynecologic hemorrhages (literature survey)].
    Skipetrov VP
    Akush Ginekol (Mosk); 1974 Oct; (10):1-6. PubMed ID: 4280255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative studies on antifibrinolytic agents].
    Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):106-12. PubMed ID: 4173870
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrinolytic therapy: biochemical mechanisms.
    Robbins KC
    Semin Thromb Hemost; 1991 Jan; 17(1):1-6. PubMed ID: 1828622
    [No Abstract]   [Full Text] [Related]  

  • 37. [Additional potentials of a method of standard fibrin plates].
    Kovalenko AN
    Lab Delo; 1980; (10):615-8. PubMed ID: 6158612
    [No Abstract]   [Full Text] [Related]  

  • 38. On coagulation and fibrinolysis in renal failure.
    Larsson SO
    Scand J Haematol Suppl; 1971; 15():1-59. PubMed ID: 5284430
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on plasminogen activators. II. A method for the separation of purified urokinase from small samples of urine.
    Hamberg U; Savolainen ML
    Acta Chem Scand; 1966; 20(9):2551-8. PubMed ID: 5965138
    [No Abstract]   [Full Text] [Related]  

  • 40. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.